title: Predictors for mortality and loss to follow-up among children receiving anti-retroviral therapy in Lilongwe, Malawi.
abstract: OBJECTIVE
  To determine predictors of mortality in children on anti-retroviral therapy (ART) who attended the Paediatric HIV Clinic at Kamuzu Central Hospital in Lilongwe, Malawi.
  
  
  METHODS
  Retrospective case cohort study by chart review of children who had started ART between October 2004 and May 2006. Bivariable and multivariable analysis were performed with and without defaulters to evaluate associations according to vital status and to identify independent predictors of mortality.
  
  
  RESULTS
  Forty-one of 258 children (15.9%) were deceased, 185 (71.7%) were alive, and 32 (12.4%) had defaulted: 51% were female, 7% were under 18 months, 26% were 18 months to 5 years, and 54% were >5 years of age. Most were WHO stage III or IV (56% and 37%, respectively). On multivariate analysis, factors most strongly associated with mortality and defaulting were age <18 months [hazards ratio (HR) 2.11 (95% CI 1.0-4.51)] and WHO stage IV [HR 2.00 (95% CI 1.07-3.76)].
  
  
  CONCLUSIONS
  To improve outcomes of HIV-positive children, they must be identified and treated early, specifically children under 18 months of age. Access to infant diagnostic procedures must be improved to allow effective initiation of ART in infants at higher risk of death.
authors: University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
authors: Bradley C
authors: BC
authors: Fetzer
authors: Mina C
authors: MC
authors: Hosseinipour
authors: Portia
authors: P
authors: Kamthuzi
authors: Lisa
authors: L
authors: Hyde
authors: Brian
authors: B
authors: Bramson
authors: Kebba
authors: K
authors: Jobarteh
authors: Kristine
authors: K
authors: Torjesen
authors: William C
authors: WC
authors: Miller
authors: Irving
authors: I
authors: Hoffman
authors: Peter
authors: P
authors: Kazembe
authors: Charles
authors: C
authors: Mwansambo
mesh_terms: D044966:Anti-Retroviral Agents / Q000276:immunology / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count / Q000379:methods; D002648:Child; D002675:Child, Preschool; D042241:Early Diagnosis; D004812:Epidemiologic Methods; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology / Q000401:mortality*; D015497:HIV-1; D006801:Humans; D007223:Infant; D008297:Male; D010352:Patient Dropouts / Q000706:statistics & numerical data; D016896:Treatment Outcome
chemical_list: D044966:Anti-Retroviral Agents